Insider Selling: Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Director Sells $32,725.00 in Stock

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Director Riad Hussein El-Dada sold 3,500 shares of Greenland Mines Ltd. Common Stock stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $9.35, for a total value of $32,725.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Greenland Mines Ltd. Common Stock Trading Down 8.6%

Greenland Mines Ltd. Common Stock stock opened at $5.83 on Thursday. Greenland Mines Ltd. Common Stock has a 12-month low of $2.82 and a 12-month high of $36.99. The firm has a market capitalization of $70.13 million, a price-to-earnings ratio of -0.51 and a beta of 6.26. The firm has a 50 day moving average of $7.86 and a 200 day moving average of $14.75.

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) last issued its quarterly earnings results on Monday, August 17th. The company reported ($0.03) earnings per share for the quarter.

Greenland Mines Ltd. Common Stock declared that its board has authorized a share repurchase plan on Tuesday, October 6th that permits the company to buyback $20.00 million in outstanding shares. This buyback authorization permits the company to buy up to 20.4% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its shares are undervalued.

Institutional Trading of Greenland Mines Ltd. Common Stock

A hedge fund recently bought a new position in Greenland Mines Ltd. Common Stock stock. Citadel Advisors LLC purchased a new position in Greenland Mines Ltd. Common Stock (NASDAQ:GRML) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,165,648 shares of the company’s stock, valued at approximately $1,343,000. Citadel Advisors LLC owned approximately 162.60% of Greenland Mines Ltd. Common Stock as of its most recent SEC filing. 20.07% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Wall Street Zen raised Greenland Mines Ltd. Common Stock to a “sell” rating in a report on Saturday, August 29th. Weiss Ratings upgraded Greenland Mines Ltd. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, September 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

Greenland Mines Ltd. Common Stock Company Profile

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan’s Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases.